Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ER-Negative PR-Negative HER2-Negative Breast Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07581314
What this trial is testing

Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
Triple-Negative Breast Cancer (TNBC)Advanced Triple-Negative Breast CancerMetastatic Triple-negative Breast Cancer
Telomir Pharmaceuticals, Inc. 76
Early research (Phase 1)Ended earlyNCT01238133
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+6 more
National Cancer Institute (NCI) 14
Early research (Phase 1)Looking for participantsNCT04282044
What this trial is testing

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerColorectal Cancer+6 more
BioEclipse Therapeutics 60
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07698106
What this trial is testing

Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
University Health Network, Toronto 60
Testing effectiveness (Phase 2)Ended earlyNCT02273752
What this trial is testing

Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerGastrinomaGlucagonoma+16 more
Emory University 2
Testing effectiveness (Phase 2)Study completedNCT00580333
What this trial is testing

Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer

Who this might be right for
Breast Cancer
Massachusetts General Hospital 51
Early research (Phase 1)Study completedNCT01650506
What this trial is testing

Study of Erlotinib and Metformin in Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Columbia University 8
Testing effectiveness (Phase 2)WithdrawnNCT03175666
What this trial is testing

QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy

Who this might be right for
Triple Negative Breast Cancer
ImmunityBio, Inc.
Early research (Phase 1)Study completedNCT03243331
What this trial is testing

An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast CancerMetastatic Breast Cancer
Kathy Miller 18
Testing effectiveness (Phase 2)Looking for participantsNCT05485766
What this trial is testing

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast NeoplasmsTriple Negative Breast CancerBreast Neoplasms+5 more
Okayama University 23
Testing effectiveness (Phase 2)UnknownNCT05266937
What this trial is testing

Atezolizumab Plus CArboplatin Plus Nab-paclitaxel

Who this might be right for
Metastatic Breast CancerTriple Negative Breast CancerPD-L1 Gene Mutation
Consorzio Oncotech 49
Not applicableActive Not RecruitingNCT07092254
What this trial is testing

Patterns of Care and Outcomes in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Daiichi Sankyo 760
Testing effectiveness (Phase 2)Study completedNCT01815242
What this trial is testing

Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Women's Cancer Study Group GmbH 336
Very early researchStudy completedNCT03197389
What this trial is testing

Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer.

Who this might be right for
Breast CancerTriple Negative Breast CancerHormone Receptor Negative Neoplasm
Universitaire Ziekenhuizen KU Leuven 54
Early research (Phase 1)Study completedNCT02348320
What this trial is testing

Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy

Who this might be right for
Triple Negative Breast CancerTriple-Negative Breast CancerTriple Negative Breast Neoplasms
Washington University School of Medicine 18
Testing effectiveness (Phase 2)Ended earlyNCT03875313
What this trial is testing

Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaTNBC - Triple-Negative Breast Cancer+4 more
Calithera Biosciences, Inc 33
Testing effectiveness (Phase 2)Ended earlyNCT01939418
What this trial is testing

Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
National Cancer Center, Korea 23
Testing effectiveness (Phase 2)Study completedNCT02291913
What this trial is testing

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06632405
What this trial is testing

A Trial of Camrelizumab Plus Nab-paclitaxel and Levocetirizine in Metastatic or Recurrent TNBC

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 60
Next Page